Medtronic’s Interventional Spine division to promote Amgen’s Prolia in US
Prolia is approved in the US to treat postmenopausal women with osteoporosis at high risk for fracture and to increase bone mass in men with osteoporosis at high
Prolia is approved in the US to treat postmenopausal women with osteoporosis at high risk for fracture and to increase bone mass in men with osteoporosis at high
Commenting on the investment, Penn Pharma chief executive officer Richard Yarwood said the move was fuelled by its demonstrated ability to provide pragmatic and timely solutions for their
The approval, which is applicable to all 28 EU member states, has triggered $6m milestone payment to Curis from Genentech, a member of the Roche Group. Curis is
Commenting on the development Cipla managing director and global CEO Subhanu Saxena was quoted by The Economic Times as saying that the investment is aligned with the company’s
The research agreement involves the evaluation of partially refined mixtures as well as individual compounds. The aquatic environment is a source which consists of metabolically active organisms and
Under the terms of the long-term research agreement, Sobi will receive exclusive rights to commercialize XIAPEX in 28 European countries, including Switzerland, Norway, Iceland, 18 Central Eastern Europe/Commonwealth
The research agreement involves the evaluation of partially refined mixtures as well as individual compounds. The aquatic environment is a source which consists of metabolically active organisms and
Known as Fenofibric Acid Delayed-release Capsules, 45mg and 135mg is indicated for patients with mixed dyslipidemia and CHD or a CHD risk equivalent who are on optimal statin
Meeting the standards of child-resistant packaging, the new Kush containers are constructed with medical grade plastic, utilizing FDA approved material, and are BPA-free. Kush Bottles chief operating officer
A generic version of GlaxoSmithKline’s Lamictal ODT, the antiepileptic drug is indicated for the treatment of epilepsy and bipolar disorder. The company, which is the first to submit